Prostate Cancer Clinical Trials

A listing of Prostate Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1147 clinical trials
  • 0 views
  • 24 Mar, 2022
  • 1 location
Enfortumab Vedotin as Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer (ENCORE)

-resistant prostate cancer. The trial will open to enrollment in Cohort A, enfortumab monotherapy. Additional cohorts may be added as new drug combinations are identified.

  • 0 views
  • 17 Mar, 2022
  • 1 location
IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer

Dose escalation study to evaluate the safety, tolerability and anti-tumor activity of single agent IMU-935 in patients with progressive, metastatic castration resistant prostate cancer (mCRPC

  • 0 views
  • 23 Mar, 2022
  • 1 location
Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer

This is a Randomized, Active Controlled, Comparative, Open-Label, Multi-Center, Phase 3 clinical study to compare the efficacy, safety, and pharmacokinetics of leuprolide acetate for injection 3.75mg (depot) of two brands (Luprodex and Lucrin) administered in subjects with advanced adenocarcinoma of the prostate. Approximately 168 subjects (males )of age above 18 …

  • 11 views
  • 23 Mar, 2022
  • 2 locations
A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

This clinical trial is evaluating a drug called AC176 in participants with metastatic castration resistant prostate cancer (mCRPC) who have progressed on at least two prior systemic therapies

  • 0 views
  • 21 Apr, 2022
Neoadjuvant Androgen Deprivation Darolutamide and Ipatasertib in Men With Localized High Risk Prostate Cancer

This multicenter Phase I/II trial consists of two stages: a phase I stage in patients with castration resistant prostate cancer in which the recommended phase II dose will be determined for

  • 0 views
  • 03 Nov, 2021
  • 1 location
Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer

tomography (PET/CT) and multi- parameter Magnetic Resonance Imaging (MRI) guided simultaneous integrated boost for prostate cancer.

  • 0 views
  • 23 Nov, 2021
  • 1 location
The Wolverhampton Assessment Tool a Tool for Patient-reported Wellbeing in the Context of Prostate Cancer

This is a study of the Wolverhampton Assessment Tool (WATapp), a five-item questionnaire for patients with advanced or metastatic prostate cancer to say how they feel normally in terms of pain

  • 0 views
  • 10 Oct, 2021
  • 1 location
Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer (ENZA-p)

This phase 2 randomised clinical trial will investigate the activity and safety of adding Lu-PSMA to enzalutamide in patients with metastatic castrate resistant prostate cancer (mCRPC) not

renal function
bone scan
prostate adenocarcinoma
carcinoma
adenocarcinoma
  • 0 views
  • 26 Mar, 2022
  • 13 locations
Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer (Rad2Nivo)

This is an open label, prospective, trial that begins with a phase Ib safety run-in followed by a phase II expansion cohort.

nivolumab
bone metastases
prostate adenocarcinoma
adenocarcinoma
gilbert's syndrome
  • 0 views
  • 03 May, 2022
  • 1 location